60 Degrees Pharmaceuticals, Inc. Common Stock
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indicatio… Read more
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.485x
Based on the latest financial reports, 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has a cash flow conversion efficiency ratio of -0.485x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.11 Million) by net assets ($4.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
60 Degrees Pharmaceuticals, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how 60 Degrees Pharmaceuticals, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
60 Degrees Pharmaceuticals, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 60 Degrees Pharmaceuticals, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ROMNAV SA BRAILA
RO:BRNA
|
N/A |
|
Peninsula Group Ltd
TA:PEN
|
-0.033x |
|
DAYTHREE DIGITAL BERHAD
KLSE:0281
|
0.035x |
|
People's Garment Public Company Limited
BK:PG
|
-0.043x |
|
Sentage Holdings Inc
NASDAQ:SNTG
|
-0.088x |
|
Gayatri Highways Limited
NSE:GAYAHWS
|
1.168x |
|
Acsion Ltd
JSE:ACS
|
0.034x |
|
KGW Group Berhad
KLSE:0282
|
0.119x |
Annual Cash Flow Conversion Efficiency for 60 Degrees Pharmaceuticals, Inc. Common Stock (2020–2024)
The table below shows the annual cash flow conversion efficiency of 60 Degrees Pharmaceuticals, Inc. Common Stock from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.96 Million | $-5.65 Million | -1.428x | -50.83% |
| 2023-12-31 | $4.80 Million | $-4.54 Million | -0.947x | -2363.88% |
| 2022-12-31 | $-24.15 Million | $-1.01 Million | 0.042x | +16.97% |
| 2021-12-31 | $-18.15 Million | $-649.11K | 0.036x | +286.20% |
| 2020-12-31 | $-18.07 Million | $-167.30K | 0.009x | -- |